t
On 20 October 2023, Ron Russell, a Non-Executive Director of Time Finance plc, purchased 120,000 ordinary shares in the Company via UK Private Healthcare Ltd at a weighted average price of 29.52 pence per share. Following this transaction, Ron Russell's total beneficial interest in Time Finance plc amounts to 11,542,788 Ordinary Shares, representing 12.48% of the Company's issued share capital.
| Date | 23 Oct 2023 |
| Time | 08:30:59 |
| Category | Director/PDMR dealings |
| ID | 9582Q |
23 October 2023
Time Finance plc
("Time Finance", the "Group" or the "Company")
Director/PDMR Shareholding
Time Finance plc, the AIM listed independent specialist finance provider, announces that it was notified on 20 October 2023 that Ron Russell, Non-Executive Director of the Company, purchased 120,000 ordinary shares of 10 pence each in the capital of the Company ("Ordinary Shares") at a weighted average price of 29.52 pence per share, via UK Private Healthcare Ltd, on that same day. Ron Russell, together with his spouse, are interested in 50.01% of UK Private Healthcare Ltd's issued share capital.
Following this transaction, Ron Russell has a total beneficial interest in 11,542,788 Ordinary Shares, including those held by his spouse, representing 12.48% of the Company's issued share capital.
The information below, set out in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.
- Ends -
For further information, please contact:
Time Finance plc
Ed Rimmer, Chief Executive Officer 01225 474230
James Roberts, Chief Financial Officer 01225 474230
Cavendish Securities plc (NOMAD and Broker)
Ben Jeynes / Dan Hodkinson (Corporate Finance) 0207 220 000
Michael Johnson / George Budd (Sales)
Walbrook PR 0207 9338780
Paul Vann / Joe Walker 07768 807631
About Time Finance:
Time Finance's purpose is to help UK businesses thrive and survive through the provision of flexible funding facilities. It offers a multi-product range for SMEs concentrating on asset, loan and invoice finance. While focussed on being an 'own-book' lender, the Group does retain the ability to broke-on deals where appropriate, enabling it to optimize business levels through market and economic cycles.
More information is available on the Company website: www.timefinance.com.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
|
a) |
Name |
UK Private Healthcare Ltd |
||||
|
2 |
Reason for the notification |
|||||
|
a) |
Position/status |
PCA of Ron Russell, Non-Executive Director
|
||||
|
b) |
Initial notification /Amendment |
Initial notification |
||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
Time Finance plc |
||||
|
b) |
LEI |
213800VG3QJGBP2MKR86
|
||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a)
|
Description of the financial instrument, type of instrument Identification code |
Ordinary Shares of 10p each
ISIN: GB00BCDBXK43
|
||||
|
b) |
Nature of the transaction |
On market purchases of Ordinary Shares
|
||||
|
c) |
Price(s) and volume(s)
|
|
||||
|
d) |
Aggregated information - Aggregated volume
- Price |
120,000
£35,438
|
||||
|
e) |
Date of the transaction |
20 October 2023
|
||||
|
f) |
Place of the transaction |
LONDON STOCK EXCHANGE (AIMX)
|
||||